MYB and cancer: The putative driver fusion (MYB–PCCA–NFIB) and the enhancer hijacking-like mechanism (HIST1H2AG–NonGenic–ERVFRD-1) shed new light on the role of complex SVs and splicing in cancer transcriptomics.